Accumulating research has shown that how STAT3 constitutively activated in numerous types of cancer, including multiple myeloma, lymphomas, head and neck squamous cell carcinoma, breast cancer, prostate cancer, and hepatocellular carcinoma (HCC) (23–26). This evidence concerns the gene STAT3 and cancer.